“The models were smoke and mirrors for a long time. We knew we had to make things literally 100 times better for it to be valuable for real drug discovery programs,” says Chai cofounder Jack Dent
It quietly released its latest model Chai-3 earlier this year, and its founders now tell us exclusively they’ve signed a 2nd big pharma deal, with Pfizer, just 5 months after doing so with Lilly.
Really sad to see this. RIP
www.npr.org/2026/06/04/n...
With thanks to @rashis.bsky.social for additional reporting